Chronic myeloid leukemia is characterized by reciprocal translocation between chromosomes 9 and 22 t(9;22)(q34;q11), known as the Philadelphia chromosome, resulting in a BCR-ABL1 fusion oncogene. BCR-ABL1 encodes a chimeric tyrosine kinase, which is the key protein with an unregulated function resulting in neoplastic hematopoiesis and CML. It has been suggested that the first hit leading to CML development is a mutagenic event leading to the transformation of a normal hematopoietic stem cell to a premalignant progenitor cell population and subsequent generation of 
AFLP analyses
The AFLP technique can be used to detect polymorphisms in DNA when no information about the genome is known. Following restriction enzyme digestion of DNA, a subset of DNA fragments is selected for PCR amplification and separation by capillary electrophoresis. In detail, the whole procedure is shown in Figure A . AFLP is known to be highly reproducible technique for plant genomes. As well, the same results were achieved when applied on the human genome [7] . Despite that, we tested the reproducibility at the two levels. Firstly, we examined subtypes of cells isolated from the peripheral blood Preparation of the amplicon library was performed according to the manufacturer's recommendations, with modifications in several steps. To enable the ligation of adaptors with molecular identifier tags (MIDs), the ends of purified DNA fragments were blunted. Based on the results of quantification of amplicons using RT-qPCR, we determined that the adaptors self-ligated at the concentration indicated in the manufacturer's protocol (Roche Applied Science), which resulted in a product in the no template control that was visible after electrophoretic separation. Based on the optimization of adaptor concentrations, assessed using an Agilent High Sensitivity DNA Assay on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), a 100x lower concentration than that indicated in the protocol was used for further amplicon library preparation, to reduce the number of self-ligated adaptors.
To clean up the amplicon library of short fragments less than 100 bp in length, we purified the sample using a 1.8:1 ratio of Agencourt AMPure XP beads to the sample (Beckman Coulter), without the Sizing solution (Roche Applied Science), which according to the protocol, removes dsDNA of less than 300 bp and would therefore also remove the AFLP fragments of interest. The fragments were purified only once, since the second purification led to a loss of products. A total of 25 µl of the sample was added to 45 µl of Agencourt AMPure XP beads, followed by vortexing until the mixture was homogeneous. The mixture was then incubated for 10 minutes at room temperature, and the tubes were subsequently placed on a magnetic ring stand and incubated at room temperature until the supernatant was clear. The supernatant was then discarded; 100 μl of 70 % ethanol was added to each sample; and the tubes were placed on the magnetic ring stand. After clearing of the supernatant, ethanol was discarded, and the tubes were left open to vaporize the remaining ethanol.
Next, 22 µl of TE buffer was added, and the samples were mixed in a circular motion and incubated The statistical significance was evaluated using Fisher´s exact probability test. Fragments are listed from the most significant to the least significant ones for healthy donors.
Identification of AFLP markers using NGS
To evaluate the data obtained by NGS, two approaches in NextGENe software v2.4.1 (Softgenetics, State College, PA, USA) were applied, the amplicon and shotgun sequencing. The number of reads provided by both approaches are listed in Table C . n.a. -it was not possible to design primers Difficulty in scoring of absence/presence of the AFLP markers
The inconsistence of data obtained through Sanger sequencing and fragment analysis was probably caused by the difficulties in scoring two overlapping fragments CAT_ACC_54 and CAT_ACC_55, and hence resulted in misrepresentation of the statistics after fragment analysis ( Figure G and Table 2 ). 
